Last price paid | n.a. | |
Change | -4.07% [ -0.09 ] | |
Last traded volume | n.a. Unit | |
Cumulative volume | n.a. Unit | |
Date/time | n.a. n.a. |
Fixing | 17.05.2024 |
Settlement date | 01.03.2024 |
Last trading | 17.05.2024 |
Final fixing | 17.05.2024 |
Currency redemption | CHF |
Perf. since issue | +148.24% |
Year to date (YTD) | n.a. |
1 month | +105.83% |
3 months | n.a. |
1 year | n.a. |
3 years | n.a. |
Issue price | 0.85 |
Underlying price on issue | 17'368.18 |
Premium | n.a. |
Premium p.a. | n.a. |
Leverage | n.a. |
Implied volatility | n.a. |
ISIN | CH1305139912 |
Symbol | DAXZ8Z |
Security | 130513991 |
Exchange | SIX Structured Products |
Currency | CHF |
Expiry | 27.05.2024 |
Underlying | DAX® Index, DE0008469008 |
Underlying ISIN | DE0008469008 |
Strike | 17'600.00 |
C/P type | call |
Subscription ratio | 500.00 |
Issuer | Zürcher Kantonalbank |
Exercise type | European |
Delivery of securities | Automatic |
Minimum execution | 500 |
Value day | 23.02.2024 |
Premium | n.a. |
Premium p.a. | n.a. |
Leverage | 17.45 |
Implied volatility | n.a. |
Moneyness | in-the-money |
Leverage | n.a. |
Delta | n.a. |
Gamma | n.a. |
Theta | n.a. |
Rho | n.a. |
Vega | n.a. |
Fair value | 0.01 |
Intrinsic value | n.a. |
Break-even | n.a. |
SSPA value at risk | n.a. |
SSPA risk rating | n.a. |
SSPA derivative category | Leverage |
SSPA code | Warrant (2100) |
Name | Price |
---|---|
Compagnie Financi... | 144.60 |
Givaudan | 4'253.00 |
ROCHE GS | 229.80 |
Nestlé SA | 92.28 |
UBS | 28.39 |
Name | Price |
---|---|
Lonza Group | 505.80 |
Sika AG | 281.80 |
ZURICH INSURANCE | 467.70 |
NOVARTIS N | 91.37 |
Alcon AG | 81.82 |